Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: COPILOT HF
Logo

American Heart Association

  39
  0

Final ID:

Discussant: COPILOT HF

  • Van Spall, Harriette  ( McMaster University , Hamilton , Ontario , Canada )
    • Author Disclosures:
    Harriette Van Spall: DO have relevant financial relationships ; Consultant:Astra Zeneca:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Novartis - Educational Account:Past (completed) ; Consultant:Medtronic:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic - Clinical Trial Executive Committee Role:Active (exists now) ; Research Funding (PI or named investigator):Heart and Stroke Foundation of Canada:Past (completed) ; Other (please indicate in the box next to the company name):Colorado Prevention Center Clinical Research - Clinical Trial Executive Committee Role:Active (exists now) ; Other (please indicate in the box next to the company name):CardioVascular Research Foundation - Clinical Trial Events Committee:Active (exists now) ; Research Funding (PI or named investigator):Canadian Institutes of Health Research:Active (exists now) ; Other (please indicate in the box next to the company name):Boehringer Ingelheim Pharmaceuticals, Inc - Educational Account:Past (completed) ; Consultant:Bayer:Active (exists now) ; Other (please indicate in the box next to the company name):Bayer - Advisory Board:Active (exists now) ; Consultant:Baim Institute for Clinical Research:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
ANSWER-HF: A Randomized Controlled Trial of Sacubitril/Valsartan Versus Enalapril in Patients with Chronic Chagas Cardiomyopathy and Reduced Ejection Fraction

Madrini Junior Vagner, Antunes Talita, Damiani Lucas, Jose Grupi Cesar, Mathias Junior Wilson, Lopes Renato, Ramires Felix, Ramos Souza Paulo, Fernandes Fabio, Maria Ianni Barbara, Silva Martins Alan, JadÁn Luzuriaga Georgina Del Cisne, Cardoso Barbosa Fonseca Keila, Ribeiro Orlando, Bispo Da Cruz Allecineia

Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial

Lakdawala Neal, Burroughs Melissa, Claggett Brian, Costabel Juan, Correia Edileide, Dybro Anne, Elliott Perry, Kulac Ian, Lewis Gregory, Mann Amy, Nair Ajith, Garcia-pavia Pablo, Poulsen Steen, Reant Patricia, Schulze Christian, Solomon Scott, Wang Andrew, Sohn Regina, Berhane Indrias, Heitner Stephen, Jacoby Daniel, Kupfer Stuart, Maron Martin, Malik Fady, Wohltman Amy, Fifer Michael, Januzzi James, Masri Ahmad, Merkely Béla, Nassif Michael, Pena Pena Maria Luisa, Barriales-villa Roberto, Bilen Ozlem

More abstracts from these authors:
Methods Presentation: Pragmatic Trials

Van Spall Harriette

Global Rounds (Countries TBD)

Van Spall Harriette

You have to be authorized to contact abstract author. Please, Login
Not Available